Skip to main content

Peer Review reports

From: Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Original Submission
16 Apr 2018 Submitted Original manuscript
21 Jun 2018 Reviewed Reviewer Report - Terence Williams
1 Sep 2018 Reviewed Reviewer Report - Gulden Diniz
1 Oct 2018 Author responded Author comments - Yannan Zhao
Resubmission - Version 2
1 Oct 2018 Submitted Manuscript version 2
8 Oct 2018 Author responded Author comments - Yannan Zhao
Resubmission - Version 3
8 Oct 2018 Submitted Manuscript version 3
Publishing
10 Oct 2018 Editorially accepted
22 Oct 2018 Article published 10.1186/s12885-018-4936-y

You can find further information about peer review here.

Back to article page